PMA P080027S010

Device
ORAQUICK HCV RAPID ANTIBODY TEST
Applicant
OraSure Technologies, Inc.
PMA number
P080027
Supplement
S010
Product code
MZO
Decision date
2013-03-19
Classification
Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus
Generic name
Assay, enzyme linked immunosorbent, hepatitis c virus
Approval order statement
CHANGE TO AN IN-PROCESS TEST METHOD FOR HCV ANTIGENS AND CONJUGATE.

Current openFDA PMA Record#

Device
ORAQUICK HCV RAPID ANTIBODY TEST
Applicant
OraSure Technologies, Inc.
PMA number
P080027
Supplement
S010
Product code
MZO
Generic name
Assay, enzyme linked immunosorbent, hepatitis c virus
Decision date
2013-03-19
Decision code
OK30
Date received
2013-02-21
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
CHANGE TO AN IN-PROCESS TEST METHOD FOR HCV ANTIGENS AND CONJUGATE.